Geisinger president and CEO to deliver keynote at precision medicine conference
,
Dr. David Feinberg to discuss Geisinger's pioneering efforts
DANVILLE, Pa. – David T. Feinberg, M.D., MBA, Geisinger president and CEO, will serve as the keynote speaker at the Precision Medicine for Hospital CEOs Conference, an intensive one-day summit where experts from the nation’s most successful precision medicine clinical programs gather to share strategies and lessons learned.
The event will be held February 21st at the Convene Cira Centre in Philadelphia, Pennsylvania.
Dr. Feinberg’s presentation, entitled “Geisinger’s Path Forward with Precision Medicine,” will explore key learnings from the health system’s extensive work in genomic research, providing a roadmap for large-scale DNA sequencing for other institutions. His session will deliver insights into the early successes of precision medicine at Geisinger, and how the organization’s big database will be used to introduce population health initiatives while also guiding personalized care that clinicians deliver to individual patients daily.
Geisinger is internationally recognized for its pioneering efforts to bring precision health into daily clinical care. Dr. Feinberg will discuss strategies in genomic medicine, how Geisinger’s MyCode Community Health Initiative has signed up more than 180,000 participants and is returning clinical results to patients who are at high risk for early onset cancers (breast, ovarian, colon), early onset cardiac events (heart attack, stroke) and several other potentially preventable conditions.
“We have this genetic information, along with clinical information, along with 20 years’ worth of electronic health records data for four generations of families and we're returning results to our patients – what is now called precision medicine,” says Dr. Feinberg. “But what Geisinger is doing is really anticipatory medicine. We are taking a population-approach to genomics and returning medically actionable results. By doing so, it allows us to treat our patients before they get sick and helps prevent life-threatening disease. This is the future of healthcare.”
The Precision Medicine for Hospital CEOs Conference is an educational, one-day summit for hospital and health system C-Suite administrators to introduce successful implementations in the major areas of precision medicine: oncology, pharmacogenomics, infectious disease, population analytics based on big data.
The event will be held February 21st at the Convene Cira Centre in Philadelphia, Pennsylvania.
Dr. Feinberg’s presentation, entitled “Geisinger’s Path Forward with Precision Medicine,” will explore key learnings from the health system’s extensive work in genomic research, providing a roadmap for large-scale DNA sequencing for other institutions. His session will deliver insights into the early successes of precision medicine at Geisinger, and how the organization’s big database will be used to introduce population health initiatives while also guiding personalized care that clinicians deliver to individual patients daily.
Geisinger is internationally recognized for its pioneering efforts to bring precision health into daily clinical care. Dr. Feinberg will discuss strategies in genomic medicine, how Geisinger’s MyCode Community Health Initiative has signed up more than 180,000 participants and is returning clinical results to patients who are at high risk for early onset cancers (breast, ovarian, colon), early onset cardiac events (heart attack, stroke) and several other potentially preventable conditions.
“We have this genetic information, along with clinical information, along with 20 years’ worth of electronic health records data for four generations of families and we're returning results to our patients – what is now called precision medicine,” says Dr. Feinberg. “But what Geisinger is doing is really anticipatory medicine. We are taking a population-approach to genomics and returning medically actionable results. By doing so, it allows us to treat our patients before they get sick and helps prevent life-threatening disease. This is the future of healthcare.”
The Precision Medicine for Hospital CEOs Conference is an educational, one-day summit for hospital and health system C-Suite administrators to introduce successful implementations in the major areas of precision medicine: oncology, pharmacogenomics, infectious disease, population analytics based on big data.
About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.
